Frontier Medicines
San Francisco
About Frontier Medicines
Frontier Medicines is a biopharmaceutical company that develops a chemoproteomics platform to accelerate the development of medicines. Its platform integrates advanced computational approaches and machine learning to discover and pharmacologically target new binding pockets on proteins that make them accessible to small-molecule drug discovery and development.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Estimated revenue: $1K – $10K
- Total funding: $255.5M
- Funding stage: Late Stage Venture
- Last round: Series C (Jun 2024)
- Website: frontiermeds.com
- Phone: 650 457 1005
Industries & Categories
Biopharma, Biotechnology, Life Science, Pharmaceutical, Precision Medicine
Social Profiles
Canonical: https://fsome.com/organization/frontier-medicines-24891 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.